Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
MADRIGAL PHARMACEUTICALS, INC. | Director | Common Stock | 656K | $184M | $280.00 | Jun 25, 2024 | By SQN LLC |
MADRIGAL PHARMACEUTICALS, INC. | Director | Common Stock | 186K | $52.2M | $280.00 | Jun 25, 2024 | Direct |
Prelude Therapeutics Inc | Director | Director Stock Option (Right to Buy) | 23.5K | Jun 14, 2024 | Direct | ||
MADRIGAL PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 1.11K | Jun 25, 2024 | Direct | ||
ALEXION PHARMACEUTICALS, INC. | Director | Common Stock, par value $.0001 per share | 0 | $177.00 | Jul 21, 2021 | Direct |